During the past decade, National MS Center Melsbroek conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National MS Center Melsbroek" #1 sponsor was "Hasselt University" with 5 trials, followed by "National MS Center Melsbroek" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Galapagos NV" with 1 trials sponsored and "Universitair Ziekenhuis Brussel" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National MS Center Melsbroek" #1 collaborator was "National MS Center Melsbroek" with 6 trials as a collaborator, "Revalidatie & MS Centrum Overpelt" with 5 trials as a collaborator, "Jessa Hospital" with 1 trials as a collaborator, "Research Foundation Flanders" with 1 trials as a collaborator and "University Ghent" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "National MS Center Melsbroek" are "Multiple Sclerosis" (9 trials), "Acute Exacerbation of Remitting Relapsing Multiple Sclerosis" (1 trials), "Cerebral Lesion" (1 trials), "Clinically Isolated Syndrome" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "National MS Center Melsbroek" in a lesser frequency.

Most popular intervention types in "National MS Center Melsbroek" are "Other" (5 trials), "Drug" (2 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (2 trials), "Assessment of walking-related fatigability" (1 trials), "Clinical Scapular protocol (ClinScaP)" (1 trials), "Cognitive training" (1 trials) and "Magnetic resonance imaging (MRI)" (1 trials). Other intervention names were less common.

The vast majority of trials in "National MS Center Melsbroek" are 12 trials for "All" genders.

Currently, there are NaN active trials in "National MS Center Melsbroek". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in National MS Center Melsbroek, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National MS Center Melsbroek, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".